Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Src Homology Phosphatase 2 Disruption in Podocytes Attenuates Markers of Aristolochic Acid 1-Induced Renal Injury, Inflammation, and Fibrosis in Mice.

Created on 14 Nov 2026

Authors

Ming-Fo Hsu, Fawaz G Haj

Published in

International journal of molecular sciences. Volume 27. Issue 20. Oct 21, 2026. Epub Oct 21, 2026.

Abstract

Aristolochic acid nephropathy (AAN) is a tubulointerstitial kidney disease caused by ingestion of aristolochic acids (AA). It is a global health concern, with no established disease-modifying therapy. Src homology phosphatase 2 (Shp2; encoded by Ptpn11) is a ubiquitously expressed protein tyrosine phosphatase that is implicated in renal development and function, but its contribution to AAN is unknown. Mice with podocyte-specific Shp2 disruption (Ptpn11fl/fl;Pod-Cre; KO) and controls (Ptpn11fl/fl) were subjected to weekly intraperitoneal injections of saline or aristolochic acid 1 (AA1, 5 mg/kg) for 4 consecutive weeks. Afterward, animals were sacrificed at 6 and 11 weeks. Renal Shp2 protein and immunofluorescence staining, including in glomeruli, were elevated following AA1 challenge. Relative to controls, KO mice exhibited attenuation of AA1-evoked changes in renal function indices, including kidney-to-body weight ratio, blood urea nitrogen, and urine albumin-to-creatinine ratio. Additionally, AA1-induced elevation in blood pressure was reduced in KO mice. At the molecular level, Shp2 deficiency was associated with significantly lower AA1-induced renal expression of inflammatory (Ccl2, Tnf) and fibrotic (Acta2, Col1a1) markers compared with controls. Histologically, AA1-induced renal interstitial collagen deposition, evaluated by picrosirius red staining, was significantly reduced in KO mice compared with controls. These findings indicate that podocyte Shp2 deficiency confers beneficial effects and attenuates AA1-induced renal injury, inflammation, and fibrosis, and identify Shp2 as a target in AAN.

PMID:
42942101
Bibliographic data and abstract were imported from PubMed on 14 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement